Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
DENTSPLY Sirona Inc (NASDAQ: XRAY) closed the day trading at $25.00 down -4.29% from the previous closing price of $26.12. In other words, the price has decreased by -$4.29 from its previous closing price. On the day, 2.94 million shares were traded. XRAY stock price reached its highest trading level at $25.76 during the session, while it also had its lowest trading level at $24.62.
Ratios:
For a better understanding of XRAY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 18.16 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.92. For the most recent quarter (mrq), Quick Ratio is recorded 0.87 and its Current Ratio is at 1.33. In the meantime, Its Debt-to-Equity ratio is 0.72 whereas as Long-Term Debt/Eq ratio is at 0.60.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Needham on August 20, 2024, Reiterated its Buy rating and also kept its target price maintained to $34.
On February 26, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $42.
On November 16, 2023, Needham started tracking the stock assigning a Buy rating and target price of $35.Needham initiated its Buy rating on November 16, 2023, with a $35 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’24 when LUCIER GREGORY T bought 8,212 shares for $24.35 per share. The transaction valued at 199,983 led to the insider holds 66,661 shares of the business.
LUCIER GREGORY T bought 3,577 shares of XRAY for $99,976 on May 31 ’24. The Director now owns 58,374 shares after completing the transaction at $27.95 per share. On Nov 22 ’23, another insider, LUCIER GREGORY T, who serves as the Director of the company, bought 10,000 shares for $31.44 each. As a result, the insider paid 314,400 and bolstered with 43,121 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 5067850240 and an Enterprise Value of 7022849024. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.30 while its Price-to-Book (P/B) ratio in mrq is 1.65. Its current Enterprise Value per Revenue stands at 1.803 whereas that against EBITDA is 11.475.
Stock Price History:
Over the past 52 weeks, XRAY has reached a high of $37.60, while it has fallen to a 52-week low of $23.58. The 50-Day Moving Average of the stock is -2.22%, while the 200-Day Moving Average is calculated to be -15.76%.
Shares Statistics:
Over the past 3-months, XRAY traded about 2.75M shares per day on average, while over the past 10 days, XRAY traded about 2075530 shares per day. A total of 207.20M shares are outstanding, with a floating share count of 201.14M. Insiders hold about 0.78% of the company’s shares, while institutions hold 106.38% stake in the company. Shares short for XRAY as of 1726185600 were 17167482 with a Short Ratio of 6.23, compared to 1723680000 on 15387409. Therefore, it implies a Short% of Shares Outstanding of 17167482 and a Short% of Float of 9.71.
Dividends & Splits
XRAY’s forward annual dividend rate is 0.62, up from 0.6 a year ago. Against a Trailing Annual Dividend Yield of 0.022970904The stock’s 5-year Average Dividend Yield is 1.19.
